News coverage about Cabot (NYSE:CBT) has been trending somewhat positive recently, according to Accern Sentiment. Accern identifies negative and positive news coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Cabot earned a media sentiment score of 0.16 on Accern’s scale. Accern also assigned press coverage about the specialty chemicals company an impact score of 45.8787302792705 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
Here are some of the news stories that may have effected Accern Sentiment’s analysis:
CBT has been the subject of a number of analyst reports. Zacks Investment Research raised Cabot from a “hold” rating to a “buy” rating and set a $75.00 price target for the company in a report on Wednesday, January 17th. SunTrust Banks raised Cabot to a “buy” rating and set a $73.00 price target for the company in a report on Tuesday, January 16th. Loop Capital raised Cabot from a “hold” rating to a “buy” rating and set a $82.00 price target for the company in a report on Friday, January 5th. ValuEngine raised Cabot from a “hold” rating to a “buy” rating in a report on Sunday, December 31st. Finally, Jefferies Group reissued a “buy” rating and issued a $74.00 price target on shares of Cabot in a report on Friday, November 3rd. Four research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $70.67.
Shares of Cabot (NYSE CBT) traded up $0.27 on Monday, reaching $67.85. The company had a trading volume of 587,842 shares, compared to its average volume of 430,648. Cabot has a 1 year low of $50.21 and a 1 year high of $68.08. The stock has a market capitalization of $4,200.00, a P/E ratio of 17.81, a P/E/G ratio of 1.78 and a beta of 1.11. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.70 and a quick ratio of 1.17.
Cabot (NYSE:CBT) last announced its quarterly earnings data on Tuesday, October 31st. The specialty chemicals company reported $0.91 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.93 by ($0.02). Cabot had a net margin of 8.87% and a return on equity of 15.11%. The firm had revenue of $723.00 million for the quarter, compared to analyst estimates of $683.30 million. During the same quarter in the previous year, the company earned $1.00 EPS. The company’s quarterly revenue was up 16.8% compared to the same quarter last year. sell-side analysts anticipate that Cabot will post 3.8 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 9th. Shareholders of record on Friday, February 23rd will be paid a dividend of $0.315 per share. This represents a $1.26 annualized dividend and a yield of 1.86%. The ex-dividend date of this dividend is Thursday, February 22nd. Cabot’s payout ratio is currently 33.07%.
TRADEMARK VIOLATION NOTICE: This article was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this article on another domain, it was stolen and reposted in violation of US & international trademark and copyright laws. The correct version of this article can be viewed at https://www.dispatchtribunal.com/2018/01/23/cabot-cbt-getting-somewhat-favorable-media-coverage-analysis-shows.html.
Cabot Company Profile
Cabot Corporation is a global specialty chemicals and performance materials company. The Company operates through four business segments: reinforcement materials, performance chemicals, purification solutions and specialty fluids. Reinforcement materials’ rubber grade carbon blacks are used to enhance the physical properties of the systems and applications in which they are incorporated.
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.